Home > PJ > Special feature
Return to PJ Online Home Page The Pharmaceutical Journal Vol 266 No 7141 p433-441
March 31, 2001

Special feature

Pharmaceutical care

(12) Mood disorders: drug treatment of depression

By Karen Fraser, MSc, MRPharmS,
Morag Martin, BSc, MRPharmS,
Robert Hunter, MD, MRCPsych,
and Steve Hudson, MPharm, FRPharmS

In this, the second part of our mood disorder feature, the drug treatment of depression is discussed. The first part (PJ, February 24, p259) covered the clinical presentation and public health implications of mood disorders. The final part of this feature, to be published at a later date, will focus on the drug treatment of bipolar disorders


This article is available as a PDF file, here


  • Ms Fraser is medicines information and research pharmacist, Greater Glasgow primary care NHS trust
  • Ms Martin is principal pharmacist (clinical services), Greater Glasgow primary care NHS trust
  • Dr Hunter is consultant psychiatrist and director of research and development, Greater Glasgow primary care NHS trust
  • Professor Hudson is Boots professor of pharmaceutical care, pharmaceutical care health service unit, department of pharmaceutical sciences, University of Strathclyde, Glasgow, and Scottish Executive national specialist in pharmaceutical care

Back to Top



©The Pharmaceutical Journal